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Functionalized iron oxide nanoparticles for
controlling the movement of immune cells†
Ethan E. White,‡a,b Alex Pai,‡c Yiming Weng,‡a Anil K. Suresh,‡a Desiree Van Haute,a,b
Torkom Pailevanian,c Darya Alizadeh,a,d Ali Hajimiri,*c Behnam Badie*d and
Jacob M. Berlin*a,b
Immunotherapy is currently being investigated for the treatment of many diseases, including cancer. The
ability to control the location of immune cells during or following activation would represent a powerful
new technique for this ﬁeld. Targeted magnetic delivery is emerging as a technique for controlling cell
movement and localization. Here we show that this technique can be extended to microglia, the primary
phagocytic immune cells in the central nervous system. The magnetized microglia were generated by
loading the cells with iron oxide nanoparticles functionalized with CpG oligonucleotides, serving as a
proof of principle that nanoparticles can be used to both deliver an immunostimulatory cargo to cells and
to control the movement of the cells. The nanoparticle-oligonucleotide conjugates are eﬃciently interna-
lized, non-toxic, and immunostimulatory. We demonstrate that the in vitro migration of the adherent,
loaded microglia can be controlled by an external magnetic ﬁeld and that magnetically-induced migration
is non-cytotoxic. In order to capture video of this magnetically-induced migration of loaded cells, a novel
3D-printed “cell box” was designed to facilitate our imaging application. Analysis of cell movement
velocities clearly demonstrate increased cell velocities toward the magnet. These studies represent the
initial step towards our ﬁnal goal of using nanoparticles to both activate immune cells and to control their
traﬃcking within the diseased brain.
1. Introduction
Immunotherapy is an attractive treatment strategy for many
diseases, including cancer.1 Generally, this strategy involves
stimulating the immune system such that it recognizes the dis-
eased cells as foreign and eliminates them. A wide variety of
agents, ranging from antibodies, to engineered immune cells,
to potent adjuvants have been used to stimulate the immune
system. Immunotherapy would be greatly enhanced as a treat-
ment strategy if the location of the immune cells both during
and after stimulation could be controlled. For the case of
cancer immunotherapy, it could be of great benefit to direct
activated immune cells to the tumor in order to promote
antigen recognition specifically for cancer cells. Furthermore,
the immune response could be enhanced by maintaining a
population of activated immune cells at the primary tumor
site and/or improving the traﬃcking of activated immune cells
to distant foci of disease.
We have been pursuing the use of oligodeoxynucleotides
that contain an unmethylated CpG motif (CpG) as immune
stimulants for the treatment of glioblastoma. CpG is known to
be immunostimulatory by activating toll like receptor-9 (TLR9)
which is expressed by normal and glioma-associated human
microglia and macrophages.2–5 Activation of TLRs enhances
the uptake of microorganisms by phagocytic cells, promotes
secretion of Th1 cytokines, and mediates leukocyte recruit-
ment to infected tissues. Generally, TLR9 is not found on the
cell surface, but is initially located in the endoplasmic reticu-
lum (ER) and is then found colocalized with CpGs in the
lysosomes following stimulation.6 Therefore, because CpG-
induced immune stimulation is dependent upon TLR9 inter-
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acting with CpG inside the endosomal compartment, using a
platform that achieves endosomal delivery of CpG may be an
attractive strategy for enhancing CpG eﬃcacy.7
Nanoparticles are appealing delivery platforms for CpG
because, in general, nanoparticles are rapidly endocytosed by
phagocytic immune cells.8 Various nanoparticles have been
investigated as potential candidates for the delivery of CpGs,
including liposomes,9 self-assembling DNA nanoparticles,10
poly(lactic-co-glycolic acid) nanoparticles11 and gold nanoparti-
cles.12 For the treatment of brain cancers, we recently reported
that the use of single-walled carbon nanotubes as delivery
vehicles for CpG dramatically increased the eﬃcacy of the
CpG, such that a single intracranial injection of the nanotube-
CpG construct cured 60% of glioma-bearing mice.13,14 More-
over, when mice that were cured by treatment with the nano-
tube-CpG construct were rechallenged with a subcutaneous
injection of GL261 glioma cells, every mouse rejected the
cancer cells, demonstrating a successful induction of systemic
immunity.
This nanotube-CpG construct is readily taken up by macro-
phages, microglia, NK cells and dendritic cells.13 We hypoth-
esized that using super paramagnetic iron oxide nanoparticles
(SPIONs) as the delivery platform for the CpG would enable
magnetic control of immune cells that endocytosed the par-
ticles. SPIONs respond to magnetic fields and allow for the
controlled delivery of conjugated chemotherapeutics.15 This
technique may even allow for targeted delivery deep within the
body.16,17 Magnetic targeting of drug delivery has been applied
to brain tumors.18 Recently, magnetic targeting has been
extended to cells by labeling desired cell populations with
SPIONs and other magnetic particles. One focus of this work
has been attracting loaded cells to magnetized implanted
devices, such as stents.19,20 Another primary application
has been targeting loaded stem cells for regenerative
medicine.21–24 A limited number of publications have also
described magnetic control of loaded immune cells.25 Clini-
cally, we envision that a SPION-based immunotherapy could
be injected intracranially, internalized by local immune cells,
and then enable the magnetically-controlled migration of
these activated immune cells for the treatment of multifocal
disease or deep brain tumors.
Here we demonstrate that SPION-CpG conjugates are
eﬃciently internalized by microglia which allows for magnetic
control of the loaded cells. The synthesis and characterization
of the SPION-CpG conjugates is described. Furthermore,
the SPION-CpG conjugates are shown to be non-toxic and
immunostimulatory.
2. Results and discussion
The long-term goal of this research is to generate an iron-
oxide-based cancer immunotherapy that enables magnetically-
guided, modular localization of activated immune cells in vivo.
The objective of this manuscript is to provide proof-of-prin-
ciple evidence that adherent, microglia-like immune cells can
be loaded with immunostimulatory particles and moved by
magnetic fields in vitro. To perform the in vitro magnetic field
influenced cell movement studies, SPION-CpG conjugates
(Fig. 1A) were prepared from 30 nm SPIONs (Fig. S1A†). The
synthetic protocol was intended to produce CpG conjugated to
PEG with a terminal silyl ether for conjugation to the SPIONs,
but Mass Spectrometry (MS) analysis (Fig. S1C†) indicated that
the reduction of RSSCpG was ineﬃcient and thus the majority
of material used to coat the SPIONs was likely RSSCpG. None-
theless, it was clear that a functional coating was achieved as
demonstrated by the change in aqueous stability of the
SPIONs. The as-received SPIONs were coated with oleic acid
and thus not miscible with water, but, following sonication
with the CpG-containing material, the SPIONs entered the
aqueous phase. Furthermore, zeta potential measurements
showed the resulting SPION-CpG particles to be negatively
charged, consistent with an oligonucleotide coating (Fig. 1B).
Dynamic light scattering measurements indicated that the
SPION-CpG conjugates have a hydrodynamic diameter of
Fig. 1 Synthesis and characterization of the SPION-CpG conjugates. (A)
Schematic illustration of the synthesis of SPION-CpG conjugates. (B)
Hydrodynamic diameter and zeta potential of SPION-CpG conjugates.
(C) Transmission electron microscopy image of the SPION-CpG conju-
gates. (D) LIVE/DEAD stain of N9 cells treated with 0.5 mg mL−1 for 12 h.
Red = ethidium homodimer (dead), green = calcein AM (live). (E) NFκB
activation of RAW-Blue™ mouse macrophage reporter cells treated with
0.1 mg mL−1 SPION-CpG (n = 2, 6 replicates each). The average of the
normalized data from two assays is shown.
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94 ± 5 nm, as compared to 46 ± 2 nm for the free SPIONs
(Fig. 1B). This is likely the result of small aggregates forming
following the coating, as revealed by transmission electron
microscopy (TEM, Fig. 1C).
Cell assays indicated that SPION-CpG was both non-cyto-
toxic (Fig. 1D) and immunostimulatory (Fig. 1E). The LIVE/
DEAD assay was used to evaluate cell viability of N9 mouse
microglia cells after 12 h of loading at SPION-CpG concen-
trations up to 0.5 mg mL−1. As shown in Fig. 1D and Fig S1D,†
the treated cells exhibited an equivalent level of viability as
untreated control cells. In order to evaluate the immunostimu-
latory potential of SPION-CpG, an NFκB reporter cell line was
used. Because NFκB activity is increased in response to TLR9
activation by CpG, immune stimulation by SPION-CpG was
expected to cause an increase in NFκB signal within this re-
porter system. Indeed, SPION-CpG treatment induced an increase
in NFκB activity when compared to untreated cells (Fig. 1E).
However, the NFκB activity of SPION-CpG was less than an
equivalent amount of free CpG (RSSCpG). This reduction in
activity has several possible causes. It is possible that some
CpG was lost during the SPION-CpG synthesis process, thus
resulting in lower NFκB activity after uptake by reporter cells.
It is also possible that the immunostimulatory activity of CpG
was partially inhibited by conjugation to SPIONs. Phosphate
groups are well-known for their ability to bind the surface of
iron oxide.26,27 Therefore it is likely that the phosphorothioate
backbone of the CpG oligonucleotide interacted with the
surface of the SPIONs, interfering with CpG release or its
binding to TLR9.28 Future work will focus on investigating the
mechanism of this phenomenon and further enhancing the
immunostimulatory activity of SPION-CpG.
Next, inductively coupled plasma mass spectrometry
(ICP-MS) was used to quantify the cellular uptake of the
SPION-CpG by N9 microglia. Briefly, cells were treated with
increasing concentrations (0, 0.01, 0.1, 0.3 and 0.5 mg mL−1)
of SPION-CpG conjugates for 12 h, washed thoroughly,
digested with nitric acid and analyzed using ICP-MS. A dose-
dependent increase in iron content above the normal back-
ground level in control cells was observed (Fig. 2E). For
comparison, cells were also treated with the commercially
available Ferumoxytol iron oxide nanoparticles (sold under the
name Feraheme®), which are approved for human use by the
US Food and Drug Administration. Ferumoxytol particles are
similar in size to the SPIONs used in this study, with an iron
core diameter of 17–30 nm.29 However, even when cells were
exposed to a 3× higher concentration of Ferumoxytol as com-
pared to SPION-CpG, very little uptake of the Ferumoxytol par-
ticles was observed. While there are a number of diﬀerences
between our SPION-CpG and Ferumoxytol, we speculate that
this increased loading of SPION-CpG was due to the olig-
onucleotide coating. It has previously been shown that oligo-
nucleotide coatings lead to enhanced cell uptake mediated by
scavenger receptors.30,31 Independent of the mechanism
responsible, the enhanced uptake for our SPION-CpG made
this material appealing for use in the magnetic control of
microglia.
Further, dark-field microscopy imaging was performed to
show the uptake and distribution of the particles over a rela-
tively large area. N9 cells treated with SPION-CpG conjugates
at a concentration of 0.5 mg mL−1 were assessed using a dark-
field microscope. Untreated control cells showed no uptake
(Fig. 2A), whereas cells treated with SPION-CpG conjugates
showed profound uptake of the SPIONs (Fig. 2B). TEM
imaging was also performed to gather information on the
intracellular distribution of the SPION-CpG conjugates. At low
magnification, TEM imaging performed across various regions
of the grid revealed strong uptake of the SPION-CpG conju-
gates, in agreement with dark-field microscopy. Higher magni-
fication TEM imaging showed dense aggregates of particles
that were predominantly located in intracellular vesicles
Fig. 2 SPION-CpG is internalized in N9 cells. Dark-ﬁeld images of (A)
microglia cells alone and (B) cells loaded with SPION-CpG conjugates
[0.5 mg mL−1]. (C, D) TEM images of loaded cells. (E) ICP-MS analysis of
cells treated with increasing concentrations of SPION-CpG conjugates
and Ferumoxytol (treatments performed with 8 replicates). (F) ICP-MS
analysis of cell and supernatant fractions at various time points after
loading (n = 2 with treatments performed in triplicate, average of two
experiments is shown). Error bars represent standard deviations of iron
content in replicate wells.
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(Fig. 2C–D). Some particles were observed in the cytoplasm as
well, and no particles were found in the nucleus. Similarly, no
uptake was observed in the untreated control cells
(Fig. S2A–B†).
After verifying that SPION-CpG was internalized by N9 cells,
the exocytosis of these particles was then investigated. This
has important implications in experiments involving magneti-
cally-induced movement. As a cell exocytoses SPIONs, its
responsiveness to magnetic fields will decrease as a function
of the amount of residual intracellular iron. Thus the rate of
exocytosis aﬀects the time period over which the cells can be
moved in vitro. In order to track the rate of exocytosis, N9 cells
were loaded and the iron content of both the cells and the cell
media was measured at 0, 8, and 24 h after loading. Over a
24 h period, there was no detectable increase in the iron
content of the cell media nor was there a detectable decrease
in the iron content of the cell fraction (Fig. 2F). Therefore, we
concluded that exocytosis of SPION-CpG was negligible in N9
cells over 24 h. The background iron level in the media at 0 h
was presumably residual free SPION-CpG which was not
removed when the loaded cells were washed with PBS two
times. Longer time points were not investigated because 24 h
proved suﬃcient to demonstrate robust in vitro movement.
As a simple test to evaluate if SPION-CpG-loaded microglia
could be controlled with an external magnetic field, three
diﬀerent shaped magnets were placed underneath glass
bottom culture dishes containing adherent N9 cells loaded
with SPION-CpG. After 20 h, the media was aspirated, the
plates were stained with Prussian blue, and photographs were
taken to demonstrate the shape-dependent localization of the
loaded cells (Fig. 3A). Additionally, this magnetically con-
trolled cell movement was correlated with the dose of
SPION-CpG given to the cells, with higher loadings leading to
more pronounced accumulation at the magnet (Fig. S3A–C†).
As controls, we also imaged SPION-CpG particles only with
magnet exposure, untreated cells with magnetic exposure and
cells loaded with SPION-CpG that were not exposed to any
magnets. The SPION-CpG only control shows almost no adher-
ence of the particles, such that following staining and
washing, very little material remained in the dish (Fig. 3D).
Neither “empty” cells that were exposed to the magnet nor
loaded cells not exposed to the magnet migrated in vitro, con-
firming that the shape-dependent localization of the loaded
cells was magnetically controlled (Fig. 3B–C). In order to more
closely monitor the magnetically induced migration of the
cells, higher magnification images were recorded for loaded
cells after 0, 2, 4, and 20 h of magnet exposure (Fig. S4M–P†).
Accumulation of the loaded cells at the edge of the magnet
where the magnetic field gradient was largest was observed by
4 h and increased until 20 h. Collectively, these controls
demonstrate that the accumulation at the edge of the magnet
was due to SPION-loaded cells moving in response to the mag-
netic field.
In order to verify that magnetically-induced movement was
nontoxic, the migrated cells were examined for changes in via-
bility and cell morphology. Because the migrated cells com-
prise only a small percentage of the total cell population of the
dish, assays that analyze the bulk cell population would not be
Fig. 3 Magnetically induced movement of the cells loaded with SPION-CpG conjugates. The concentration of SPION-CpG used for loading was
0.1 mg mL−1. (A) Color images of loaded cells after exposure to magnets of diﬀerent shapes for 20 h. (B–D) are the various controls used for the
magnetic movement experiments, stained with Prussian blue to facilitate visualization; (B) loaded cells not exposed to the magnet, (C) unloaded
cells exposed to the magnet, and (D) SPION-CpG only without cells. (E, F) SEM images of cells after movement. (G, H) Brightﬁeld and ﬂuorescent
images of LIVE/DEAD-stained cells after movement.
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able to detect changes in the migrated cell population due to a
high background signal from the non-migrated cells. Further-
more, there is no good way to separate the migrated and non-
migrated cell populations prior to analysis. Therefore, analysis
of the migrated population was performed using imaging-
based techniques. Imaging-based techniques allow the spatial
information from the cells to be preserved during the analysis,
enabling quick identification of migrated and non-migrated
populations.
Viability and cell morphology were examined via the LIVE/
DEAD assay and SEM, respectively. After loaded cells were
exposed to the magnet for 20 h and clear migration was
observed, the cells in the dish were stained with calcein AM
and ethidium homodimer, fixed, and then fluorescently
imaged to assess viability. After fluorescent imaging, the same
region of cells was imaged by SEM. No decrease in cell viability
was detected for migrated cells nor were any gross abnormal-
ities in cell morphology observed (Fig. 3E–H, S3D–G†).
The movement of cells loaded with SPION-CpG conjugates
is primarily determined by the external magnetic field profile
and strength, the hydrodynamic properties of the cell in its
environment, and the eﬀectiveness of SPION uptake by the
cells. An important evaluation of cell motility is the quantifi-
cation of movement velocity. Therefore, in order to analyze
the movement velocity of cells, an innovative imaging, incu-
bation, and magnetic manipulation apparatus was designed
(Fig. S4Q†). The apparatus consists of a custom “cell box”
fitted onto a standard sized petri dish. N9 cells were plated
onto the coverslip portion of the cell box and then loaded with
SPION-CpG. After cell loading, the entire box assembly was
then inverted into a petri dish containing culture medium. For
time-lapse imaging, the cell box and petri dish were placed
onto the stage of an inverted microscope equipped with incu-
bation capabilities. A ceramic permanent magnet was then
placed on the opposite side of the coverslip to which the cells
were attached.
During magnet exposure, the cells were imaged at 2 frames
min−1 for a period of 20 h. Cell positions were extracted using
an image processing algorithm.32 The distribution of cell velo-
cities in the vertical direction (toward the magnet) and hori-
zontal direction is shown in Fig. 4A–B. The histograms in
Fig. 4A–B show that the cell movement in the horizontal direc-
tion was symmetrical, while cell movement in the vertical
direction was skewed toward the externally-applied magnetic
field. In some cases cells migrated toward the magnet at
velocities exceeding 30 μm min−1.
3. Experimental
Ultrasonication was performed using a QSONICA Sonicator
Q700 (QSONICA, Newtown, CT, USA) equipped with a cup horn
cooled with running water from the sink. Super paramagnetic
iron oxide nanoparticles (30 nm, catalogue #SOR-30) were pur-
chased from Ocean Nanotech, Springdale, AR, USA. Silane-
PEG-NH2 (MW = 2000, Catalogue #PG2-AMSL-2k) was pur-
chased from NANOCS. Dithiotheritol (DTT) was purchased
from VWR. Fully phosphorothioated CpG oligonucleotides
bearing a terminal dithiol (5-HO-C6-SS-C6-T*A*A*A*C*G*T*-
T*A*T*A*A*C*G*T*T*A*T*G*A*C*G*T*C*A*T*-3) (RSS-CpG)
was provided by the DNA/RNA Core Facility at Beckman
Research Institute at City of Hope. Sulfosuccinimidyl 6-(3′-[2-
pyridyldithio]-propionamido)hexanoate (Sulfo-LC-SPDP) was
purchased from ProteoChem (catalogue #c1118). Illustra
NAP-25 columns (catalogue #17-0852-01) were purchased
from GE Healthcare. All other chemicals and reagents were
from standard commercial sources. N9 cells were cultured
in Dulbecco’s Modified Eagle Medium (with high glucose,
L-glutamine, sodium pyruvate) supplemented with 10% fetal
bovine serum (FBS), HEPES (0.01 M), penicillin (100 U mL−1),
and streptomycin (100 μg mL−1) incubated at 37 °C in a
humidified 5% CO2 atmosphere. For movement experiments,
cells were cultured in glassbottom dishes (MatTek Corpor-
ation, catalogue # P35G-0-14-C). Coverslip removal fluid (cata-
logue # P DCF OS 30) was obtained from MatTek.
Fig. 4 Histograms of (A) horizontal and (B) vertical cell velocities in the motility experiment. Cells loaded with SPION-CpG conjugates were imaged
over a period of 12 h under the exposure of a magnetic ﬁeld. The external magnet was placed in a positive vertical position relative to the cells.
Velocities were calculated by extracting the change in cell position from one frame to the next. The average velocity was 0.2 ± 3.72 µm min−1 in the
vertical direction and 0.03 ± 1.69 µm min−1 in the horizontal direction.
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3.1. SPION-CpG synthesis
Silane-PEG-NH2 (29 eq., 17 mM) and Sulfo-LC-SPDP (17 eq.,
10 mM) were dissolved in deionized water and stirred for
2 hours at room temperature. Meanwhile, RSS-CpG (1 eq.) was
dissolved in deionized water containing at least 2.5 mM DTT
and stirred for 2 hours at room temperature. DTT-treated
RSS-CpG was then passed through a nap-25 column (GE
Healthcare) in order to remove excess DTT. The CpG solution
was then added to the silane-PEG-NH2-containing reaction
and heated in a 60 °C oil bath for at least 2 hours. After
2 hours, the reaction was isopropanol-precipitated, dialyzed
against deionized water using a <3.5 kD MWCO membrane,
and lyophilized.
The lyophilized material was dissolved in deionized water
and diluted to an eﬀective CpG concentration of 2 mg mL−1
based on UV absorbance at 260 nm (RSSCpG ε260 nm = 261 900
L mol−1 cm−1). Then SPIONs (25 mg mL−1 in chloroform) were
combined with the product stock solution in a 1 : 1 mass ratio
(SPION : CpG). The mixture was rotated for 10 minutes and dis-
tributed into 1.5 mL microcentrifuge tubes with <1 mL in
each. To disperse the SPIONs, the sample tubes were ultra-
sonicated for a process time of 4 h (80 amplitude, 15 s on, 15 s
oﬀ ). The SPION-CpG conjugates were then dialyzed (100 kD
MWCO) against deionized water. After dialysis, the samples
were diluted to a final concentration of 1 mg mL−1 SPIONs
and 1 mg mL−1 RSSCpG (assuming no loss) using deionized
water. During synthesis of SPION-CpG, discoloration of sample
tubes and sedimentation upon dialysis membranes was
observed, indicating that some of the material was lost.
However, it was not feasible to quantify the SPION loss on
these surfaces. Similarly, the amount of CpG lost during
SPION-CpG synthesis is also diﬃcult to quantify. Therefore as
an approximation, the concentrations reported in subsequent
experiments assumed no loss of SPIONs and no loss of CpG.
At worst, when using this approximation we underestimated
the immunostimulatory potential and cell uptake eﬃciency of
SPION-CpG.
3.2. Mass spectrometry
Using 3kD MWCO centrifugal spin filters (Amicon Ultra
0.5 mL, catalogue # UFC500324, EMD Millipore), crude from
the RSSCpG reduction reaction was washed with an
ammonium acetate–acetic acid buﬀer (pH = 4.5) and de-
ionized water for desalting. The sample was introduced by
nanoelectrospray into a Thermo LTQ-FT operated in negative
ion mode under manual control. Ions were detected in the ICR
cell at resolution 100 000 (at m/z 400).
3.3. NFκB activity assay
RAW-Blue™ mouse macrophage reporter cells (Invivogen) were
cultured at 5000 cells per well (using a 96-well plate; 6 repeat
per group). Cells were treated with 10 μL of RSSCpG,
SPION-CpG, or water for 16 hours. Both RSSCpG and
SPION-CpG treated wells had the same final CpG concen-
tration (0.1 mg mL−1). The level of secreted embryonic alkaline
phosphatase (SEAP) was quantified by incubating 10 µL of
supernatant with 190 µL QuantiBlue™ substrate (InvivoGen)
for 1 h and reading absorption at 620 nm using DTX 880 Multi-
mode Detector (Beckman Coulter). QuantiBlue™ substrate
was prepared by mixing one pouch of QUANTI-Blue in 100 mL
of deionized water. The solution was then filtered using a
0.2 µm membrane. QuantiBlue™ substrate was warmed at
37 °C prior to use.
3.4. Physical characterizations
Dynamic light scattering (DLS) and zeta potential (ZP)
measurements were performed (ionic strength 10−3 M using
NaCl) on a Brookhaven 90 Plus/BI-MAS Instrument
(Brookhaven Instruments, New York). DLS measurements were
obtained by performing 10 runs at 30 s per run and the ZP
values by measuring 10 runs involving 20 cycles per run. For
the zeta potential measurements the samples were diluted to
achieve an eﬀective concentration of 0.01 w/v% (assuming no
SPION loss). Each time, prior to performing DLS and ZP
measurements the sample was ultrasonicated for 1 h.
3.5. LIVE/DEAD staining and light microscopy
Cytotoxicity assessment was performed using the LIVE/DEAD
staining assay (Invitrogen). N9 microglia cells seeded at 9.6 ×
104 cells per well in a glass bottom cell culture dish were
grown to 80% confluence. For each viability assay, the cells
were washed with PBS, treated with the SPION-CpG conjugates
and incubated for 12 h. After exposure to the diﬀerent SPIONs,
the cells were rinsed with PBS and stained with calcein-AM
and ethidium homodimer (EthD-1 or EthD-2). The dyes were
mixed together and appropriately diluted so that the eﬀective
working solution contains 2 µM of calcein-AM and 4 µM of
ethidium homodimer which was then directly added to cells
following manufacturer’s protocol. After incubation with the
dye, the cells were treated with fixative (either glutaraldehyde
for post-movement SEM samples or paraformaldehyde) and
imaged.
Light microscopy images were obtained on several instru-
ments: Nikon Eclipse TS100 microscope equipped with In-
finity2 camera (Nikon Instruments Inc., USA), Nikon Eclipse
TE2000-U Inverted Fluorescence microscope (Nikon Instru-
ments Inc., USA), Zeiss Axio Observer Z1 Inverted microscope
with a Hamamatsu EMCCD C9100-13 Monochrome Camera,
and a Zeiss LSM 710 confocal laser-scanning microscope with
a Plan-Apochromat 20×/0.8 objective (Carl Zeiss Microimaging,
Thornwood, NY). For confocal images, optical sections were
collected at 1 µm spacing and shown as a maximum intensity
projection using Zen 2009 software (Carl Zeiss). For the Zeiss
Axio Observer, Zen 2012 blue software was used.
3.6. Inductively coupled plasma mass spectroscopy (ICP-MS)
for uptake and exocytosis
To quantify the total uptake of the SPION-CpG by the micro-
glia N9 cells we performed ICP-MS (4500 Series, Hewlett
Packard) measurements. The cells were grown as described
above and treated with various concentrations of SPION-CpG
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(0, 0.01, 0.1, 0.3 and 0.5 mg mL−1) or Ferumoxytol (1.5 mg
mL−1). After 12 h of exposure, the medium was aspirated, the
cells were washed once with PBS and were collected by treating
with 0.2% trypsin-EDTA, followed by washing two times with
PBS and table-top centrifugation (1000 rpm, 5 min), acid
digested overnight using 1 mL of 67–70% BDH Aristar® Plus
Nitric Acid, and analyzed using ICP-MS upon appropriate
dilution. A standard curve was made using serial dilution of a
1 ppm solution of Iron standard solution (Spex CertiPrep).
Iron concentration was determined by ICPMS Analysis on a HP
4500 Series using a concentric nebulizer, Scott type spray
chamber, and a fixed quartz injector torch. A CX interface was
used. Plasma power was 1500 Watt. Helium was used as the
collision gas (4 mL min−1). Data was analyzed quantitatively in
a spreadsheet program.
To evaluate exocytosis, N9 cells were plated at 6000 cells per
well in a 96 well plate (18 000 cells cm−2) and allowed to
adhere for 24 h. The cells were then loaded at a 0.1 mg mL−1
concentration of SPION-CpG for 2 h. After loading, the cells
were washed twice with PBS and 150 μL fresh media was
added to each well. At t = 0 h, 8 h, and 24 h, media in the well
was completely removed (“supernatant” fraction) and both the
amount of iron in both the supernatant and cell fractions was
quantified via ICP-MS. Each group was in triplicate and two
independent experiments were performed.
ICP-MS for the exocytosis experiment was performed as
follows: 200 μL BDH Aristar® Plus Nitric Acid (70%) was added
to each sample tube (for the supernatant fraction) or well of a
96 well plate (cell fraction) to dissolve the iron. Each tube or
well was washed once with 200 μL of 70% Nitric acid, the
sample was then diluted to 3.4 mL with 3 mL of 2% nitric acid
solution. Iron concentration was determined by ICPMS Analy-
sis on Agilent 7500 Series using a concentric nebulizer, Scott
type spray chamber, and a fixed quartz injector torch. A CX
interface was used. Plasma power was 1500 Watt. Helium was
used as the collision gas (4 mL min−1). A standard curve was
made using serial dilution of a 1 ppm solution of Iron stan-
dard solution (Spex CertiPrep). Data was analyzed quantitat-
ively in a spreadsheet program.
3.7. Dark-field microscopy imaging
Cells were grown to 80% confluence on a glass bottom
cell culture dish for 24–48 h. The cells were loaded with
0.5 mg mL−1 SPION-CpG for 2 h. After loading, excess
media was removed, and the cells were washed extensively
with PBS. The cover slips were carefully detached from the
bottom of the dishes using a sharp edge forcep and allowed to
dry. A drop of non-drying immersion oil (Cargille Laboratories,
Cedar Glove, NJ) was put on the cover slip and the cover
slip was mounted onto the glass slide and was adhered
using nail polish to prevent drying. Dark-field microscopy
imaging was performed using a CytoViva dark field micro-
scope system equipped with CytoViva Hyperspectral Imaging
System 1.2.
3.8. Electron microscopy (SEM and TEM)
TEM imaging was performed on a FEI Tecnai 12 TEM
equipped with a Gatan Ultrascan 2 K CCD camera at an accel-
erating voltage of 120 kV. Cells treated with SPION-CpG conju-
gates (0.5 mg mL−1) as described earlier, were collected by
treating with 0.2% trypsin-EDTA, followed by washing with
PBS and table top centrifugation (2000 rpm, 5 min), fixed with
2% glutaraldehyde in 0.1 M Cacodylate buﬀer (Na(CH3)
2AsO2·3H2O), pH 7.2, at 4 °C overnight. The following day the
cells were washed three times with 0.1 M Cacodylate buﬀer,
post-fixed with 1% OsO4 in 0.1 M Cacodylate buﬀer for 30 min
and washed three times with 0.1 M Cacodylate buﬀer. The
samples were then dehydrated using 60%, 70%, 80%, 95%
ethanol and 100% absolute ethanol (twice), propylene oxide
(twice), and were left in propylene oxide–Eponate (1 : 1) over-
night at room temperature under sealed environment. The fol-
lowing day the vials were left open until the propylene oxide
was evaporated (∼2–3 h). The samples were infiltrated with
100% Eponate and polymerized at ∼64 °C for 48 hours. Ultra-
thin sections (∼70 nm thick) were cut using a Leica Ultra cut
UCT ultra-microtome equipped with a diamond knife, and the
sections were picked up on 200 mesh copper EM grids. The
grids were stained with 2% uranyl acetate for 10 minutes fol-
lowed by Reynold’s lead citrate staining for a minute prior to
imaging.
SEM images of the magnetically-moved cells were obtained
on an FEI Quanta 200 scanning electron microscope. Immedi-
ately after LIVE/DEAD staining, cells were fixed with 2% glutar-
aldehyde in 0.1 M Cacodylate buﬀer (Na(CH3)2AsO2·3H2O), pH
7.2, at 4 °C. The coverslip was then removed from the glass-
bottom dish using Coverslip Removal Fluid (MatTek) following
the manufacturer’s protocol. The coverslip was then washed
three times with 0.1 M Cacodylate buﬀer, pH 7.2, post-fixed
with 1% OsO4 in 0.1 M Cacodylate buﬀer for 30 min and
washed three times with 0.1 M Cacodylate buﬀer. The samples
were then dehydrated through 60%, 70%, 80%, 95% ethanol,
100% absolute ethanol (twice). The samples were dried in a
critical-point dryer and then coated with gold and palladium
(Au : Pd 60/40 ratio) in a Cressington 308R coating system.
3.9. Magnetic-field induced qualitative cell movement
in vitro by bright-field microscopy
For the magnetically induced cell movement experiments,
microglia N9 cells were cultured as described above. Cells were
seeded at 9.3 × 105 cells per dish (9.7 × 104 cells cm−2), grown
to 90% confluence and treated with various concentrations
(low: 0.1 mg mL−1, medium: 0.3 mg mL−1, and high: 0.5 mg
mL−1) of SPION-CpG conjugates. After 2 h of incubation, the
loading medium was aspirated, the cells were washed exten-
sively with PBS (carefully, until most of the free SPION-CpG
was gone), supplemented with fresh growth medium and were
placed in the incubator with magnet placed underneath the
dish separately. Further to show the controlled movement of
cells, three diﬀerent shapes of magnets were used; square,
circular, and rectangular. The movement of cells towards the
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magnet was assessed at various times (0 h, 2 h, 4 h and 20 h)
using microscopy. In order to verify that increased iron con-
centration at the edge of the magnet was SPION-CpG-loaded
cells and not free particles in solution, a cell-free SPION-CpG-
only control was included. These controls were stained for iron
using Prussian blue staining as per manufacturer’s (Poly-
science Inc. Warrington, PA) instructions. Briefly, equal
volumes of 4% potassium ferrocyanide and 4% hydrochloric
acid were mixed together to prepare the working solution. The
standard staining required at least two changes of the working
solution treatments for 10 minutes each. After which the cells
were rinsed three times with distilled water and stained using
nuclear fast red for 3 min. Finally, the cells are rinsed in
running tap water for 1 minute and imaged immediately.
3.10. Cell box design
An imaging apparatus was required to image, incubate, and
magnetically manipulate cells loaded with SPION-CpG. The
apparatus, or cell box, was inserted onto a petri dish contain-
ing cell media. It was comprised of a 3D printed ABS substrate
(Fig. S4Q†) attached to a large coverslip (48 mm × 65 mm no 1,
Ted Pella, catalogue #260365). The cell box provides an
enclosed environment for long term cell viability and prolifer-
ation while allowing for external manipulation of magnet
fields. In order to maintain the pH of cell media, exogenous
CO2 was supplied through the inlet port of the custom cell box
and evenly distributed to distribution channels inside the
petri dish. A pressure relief port prevented the accumulation of
pressure and ensured a continuous flow of atmosphere.
The cell box was printed using a 3D printer (Replicator 2,
Makerbot) and is both airtight and waterproof. The cell box
features a hollow center to enable light illumination during
bright field microscopy. A slotted coverslip face allows for
structural support of the coverslip and coverslip adhesive.
The cell box was printed with ABS filament (ABS filament,
Makerbot).
3.11. Live cell imaging
In preparation for live cell imaging, the cell box was assembled
and N9 cells plated on it. The box was first sterilized by
soaking in 0.6% NaOCl and rinsed thoroughly with autoclaved
deionized water in order to remove residual NaOCl (bleach). A
large coverslip (48 mm × 65 mm no 1, Ted Pella, catalogue
#260365) was autoclaved and attached to the cell box using a
non-cytotoxic silicone based adhesive (Silbione Med Adhesive
4100 RTV, Factor II, catalogue #A-4100). The box-coverslip
assembly was then left at room temperature in a sterile
environment (biosafety hood) for about 2 days in order to
allow the adhesive to cure. After 2 days, an autoclaved poly-
dimethylsiloxane (PDMS) dam was placed on the coverslip in
order to form a makeshift tissue culture dish. The PDMS dam
was created by first synthesizing a ∼0.5 cm thick rectangular
slab of PDMS on a clean glass surface (Sylgard 184 Silicone
elastomer kit, Dow Corning, follow manufacturer’s protocol)
and then cutting an ∼9 cm2 rectangular hole in the PDMS.
When this PDMS dam is set on the box-coverslip assembly, it
forms a water-tight seal with the coverslip. Once the dam is in
place, N9 cells (8.72 × 105 cells or 9.7 × 104 cells cm−2) were
plated on the coverslip and allowed to adhere for 8 h in the
incubator. The cells were then loaded at 0.1 mg mL−1
SPION-CpG for 2 h, following the protocol for the previous cell
movement experiment. After loading, the cells were washed
with PBS, the PDMS dam was removed and the box-coverslip
assembly was inverted into a 100 mm petri dish containing
enough media to submerge the coverslip (10–20 mL).
Live cell imaging was performed on a Zeiss Axio Observer
Z1 Inverted microscope with the Pecon/Zeiss Incubation
System. Images were obtained using a 10×/0.3 NA EC-Plan Neo-
fluar objective and a Hamamatsu EMCCD C9100-13 Mono-
chrome Camera. The microscope and camera were controlled
using the Zen 2012 Blue Edition software. After connecting the
cell box to the microscope, pre-magnet images were taken for
reference. A ceramicmagnet was then placed on top of the cover-
slip portion of the cell box above the region of the coverslip
where cells are adhered. To prevent the magnet from moving
during the experiment, the magnet was secured to the cover-
slip with tape. Using time-lapse imaging (1 brightfield image
every 30 s), the motion of cells within one field of view near
the magnet were tracked over 20 h (the same time scale used
for the other movement experiment).
3.12. Cell tracking
Cells loaded with SPION-CpG conjugates were imaged inside
the cell box for 20 h at a frame rate of 2 frames min−1 in order
to observe long-term motility. The centroid position of the cell
was determined using a computer vision algorithm as seen in
Fig. 5.32 A 2D cross correlation was computed to determine
position oﬀsets in consecutive frames. All cells move in the
same plane. The velocities of the cells were examined both in
the direction of the magnet (positive vertical direction) as well
as the horizontal direction, as seen in Fig. 4A–B. The velocity
of the cell from one frame to the next was calculated by multi-
plying the displacement in one frame by the frame rate.
Fig. 5 Tracking cells loaded with SPION-CpG conjugates under the
exposure of a magnetic ﬁeld. The cell position was calculated by identi-
fying its centroid position.32 The cell speed was calculated using the
total distance traveled between consecutive frames.
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4. Conclusions
SPION-CpG conjugates were non-toxic to N9 microglia cells
and were eﬃciently internalized into endosomal compart-
ments. This enabled magnetic control over microglia motility
in vitro. This work establishes the possibility of using a nano-
particle to both stimulate immune cells and to control their
traﬃcking. Future experiments will investigate the optimal
coating for the SPIONs to further enhance immune cell
activation.
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